Two-thirds of adults with spondyloarthritis (SpA), a family of related inflammatory conditions that includes ankylosing spondylitis (AS), reported at…
Steve Bryson PhD
Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years, within both industry and academia, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve recently stepped away from the lab and into science communications, where he’s helping make medical science information more accessible for everyone.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson PhD
People with ankylosing spondylitis (AS) face difficulties in diagnosis and treatment, must deal with the debilitating effects of disease…
Certain microRNAs, molecules involved in controlling gene activity, were dysregulated in adults with axial spondyloarthritis (axSpA), a study found. Altered…
Women with ankylosing spondylitis (AS) have a greater risk of pregnancy complications that can affect both the mother and…
The U.S. Food and Drug Administration (FDA) has approved Bimzelx (bimekizumab-bkzx) for adults with active ankylosing spondylitis (AS),…
Changes in the activity of two genes related to a type of programmed cell death called necroptosis — also implicated…
Genetic analyses found altered activity in several genes related to programmed cell death in ankylosing spondylitis (AS) patients that…
Treatment with high doses of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk of cardiovascular disease among adults…
Opioid use is highly prevalent among people in the U.S. with ankylosing spondylitis (AS), both before and after diagnosis,…
Changes in the abundance of a bacteria called Escherichia_Shigella within the digestive tract of people with inflammatory bowel disease (IBD)…